Banner - NPPA Connect

NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

News|Videos|March 5, 2025

Practicing With Swift: Impacts and Opportunities Created

Author(s)Sponsored by Swift

In this episode, Dustin Portela, DO, explores how Swift microwave therapy enhances efficiency and allows physicians to focus on other aspects of care.

Episodes in this series

EP. 1 Introduction of Swift Microwave Therapy for Wart Treatment

EP. 1 Introduction of Swift Microwave Therapy for Wart Treatment

EP. 2 Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

EP. 2 Traditional vs Microwave Wart Therapies: Insights from Swift’s Efficacy Data

EP. 3 Microwave Treatment: Advantages Over Traditional Approaches

EP. 3 Microwave Treatment: Advantages Over Traditional Approaches

EP. 4 Patient Selection and Billing Considerations for Swift Wart Treatment

EP. 4 Patient Selection and Billing Considerations for Swift Wart Treatment

EP. 5 Practicing With Swift: Impacts and Opportunities Created

EP. 5 Practicing With Swift: Impacts and Opportunities Created

EP. 6 Operational Benefits With Swift As a Delegable Procedure

EP. 6 Operational Benefits With Swift As a Delegable Procedure

EP. 7 Key Takeaways for Adding Swift Wart Treatment to Your Practice

EP. 7 Key Takeaways for Adding Swift Wart Treatment to Your Practice

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

In-Person Event

Show Me the Data: How Today’s Evidence Is Shaping Tomorrow’s Management and Prophylaxis of Chronic GVHD

February 7, 2026

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Expert Illustrations & Commentaries™: Exploring Novel Therapeutic Targets in Acne Management

Hilary Baldwin; Neal Bhatia, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Trending on Dermatology Times

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review

Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older

Introducing Dermatology Times NP/PA Connect

FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA